Press Releases

SOUTH SAN FRANCISCO, Calif., Nov. 8, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, today reported its financial results for the three and nine months ended

FRAMINGHAM, Mass., Nov. 8, 2019 /PRNewswire/ -- BERG, a clinical stage biopharmaceutical company that uses artificial intelligence (AI) to discover the underlying biology of disease, today announced results from a study of its investigational drug BPM31510 (ubidecarenone) characterizing its immunomodulatory properties ex vivo and in tumor bearing mice.

DUBLIN, Nov. 8, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented new data from the company's ARTISTRY clinical development program related to ALKS 4230 at the Society for Immunotherapy

ORLANDO, Fla., Nov. 8, 2019 /PRNewswire/ -- The American Medical Marijuana Physicians Association (AMMPA) held their 3rd Annual Conference on October 4-6 at the Hilton Orlando Lake Buena Vista. More than 300 medical marijuana practitioners and physicians from across the nation and other countries around the world attended the 3-day conf

WARSAW, Ind., Nov. 8, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the Evercore ISI HealthCONx Conference at the Four Seasons Hotel in Boston. Suky Upadhyay, Executive Vice President and Chief Financial Officer

TAMPA, Fla., Nov. 8, 2019 /PRNewswire/ -- Ultimate Medical Academy (UMA) maintained its strong support for the Women's Conference of Florida for the third consecutive year, serving as both a sponsor of the Nov. 1 main event and a presenting organization at the College Women on the Rise program, which took pla

CAMBRIDGE, Mass., Nov. 8, 2019 /PRNewswire/ -- Torque, a clinical-stage immuno-oncology company developing Deep Primed™ T cell immunotherapy to direct immune power deep within the tumor microenvironment, announced today new preclinical data for its lead Deep IL-15 Primed T cell, Deep Il-12 Primed T cell, and Deep TLR Primed T cell therapeutics programs as well as f

CHICAGO, Nov. 8, 2019 /PRNewswire/ -- Hillrom (NYSE: HRC) announced today that its board of directors declared a fiscal 2020 first quarter dividend of $0.21 per share payable on December 31, 2019, to shareholders of record as of the close of business on December 16, 2019. The indicated annual dividend rate is

INDIANAPOLIS, Nov. 8, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it will present new data from Taltz® (ixekizumab) and Olumiant® (baricitinib) at the American College of Rheumatology (ACR)/Association of Rheumatology Professionals (ARP) annual meeting taking place Nov. 8-13, 2

STAINES-UPON-THAMES, United Kingdom, Nov. 8, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, will present at the Jeffer